Heghine Khachatryan: How Well Do We Recognize Anti-PF4 Disorders?
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared Shinya Goto‘s post on LinkedIn:
“An outstanding and highly relevant review on platelet-activating anti-PF4 disorders.
For practicing clinicians, these immune-mediated thrombotic syndromes are no longer rare academic entities.
HIT, autoimmune HIT, spontaneous HIT, VITT, and VITT-like disorders are increasingly recognized across diverse clinical settings, making early suspicion, timely laboratory diagnosis, and prompt initiation of appropriate therapy essential for improving patient outcomes.
This review provides an excellent synthesis of current concepts in the pathophysiology, diagnosis, and management of anti-PF4 disorders and will undoubtedly become an important reference for physicians involved in thrombosis, hemostasis, intensive care, hematology, and vascular medicine.
Congratulations to the authors on this outstanding contribution to the field.”
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article by Theodore E. Warkentin et al., published in NEJM, adding:
“Very good review regarding Platelet-Activating Anti–Platelet Factor 4 Disorders including HIT!”
Title: Very good review regarding Platelet-Activating Anti–Platelet Factor 4 Disorders including HIT!
Authors: Theodore E. Warkentin, Andreas Greinacher
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab